Rare Disease Report interviews Chief Medical Officer Gerald Messerschmidt while at the American Society of Hematology Annual Meeting. Messerschmidt comments on the recent surge in FDA activity pertaining to rare cancer types.

To see Dr. Messerschmidt’s video interview, please click here.